Multiple myeloma: open trials in Croatia

• NCT05645107

  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Trial Treatment · Phase 3 · Grifols Therapeutics LLC

  Clinical Hospital Centre Rijeka, Rijeka · University Hospital Sveti Duh, Zagreb

  Registry updated 2026-09-30

• NCT06152575

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  Trial Treatment · Phase 3 · Pfizer

  Klinicki bolnicki centar Sestre milosrdnice, Grad Zagreb · Clinical Hospital Dubrava, Grad Zagreb · Klinički bolnički centar Osijek, Osijek · Clinical Hospital Centre Rijeka, Rijeka · KBC Split, Split · Klinicka bolnica Merkur, Zagreb · University Hospital Centre Zagreb, Zagreb

  Registry updated 2026-08-24

• NCT06932562

  A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

  Trial Treatment · Phase 3 · European Myeloma Network B.V.

  University Hospital Centre Zagreb, Zagreb

  Registry updated 2026-03-25

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error